Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on the deal while WilmerHale advised Wellington Management.MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine…
MBX Biosciences’ $115 Million Series B Financing
